文献速递先天性心脏病外科

Fontan术前或术中肺动脉扩大不增加远期不良结局:倾向匹配分析

Augmentation of the pulmonary arteries at or prior to the Fontan procedure is not associated with worse long-term outcomes: a propensity-matched analysis from the Australia-New Zealand Fontan Registry†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

基于澳大利亚-新西兰Fontan登记处1436例患者(1975-2015年)的回顾性分析,评估Fontan术前或术中行外科或经导管肺动脉扩大是否影响远期结局。未调整分析与倾向匹配分析均显示,肺动脉扩大组与非扩大组的死亡及死亡或Fontan失败风险无显著差异。

要点

  • Fontan术前或术中肺动脉扩大未显著增加死亡或Fontan失败风险。
  • 倾向匹配后死亡风险HR 1.30(95%CI 0.49-3.41,P=0.60)。
  • 研究支持对需要肺动脉扩大的Fontan患者不必因远期结局顾虑而回避干预。

核心结论

  • Fontan术前或术中行肺动脉扩大不导致更差的远期结局。

研究设计与样本

  • 回顾性队列分析澳大利亚-新西兰Fontan登记处1975-2015年1436例患者,采用Cox回归与倾向评分匹配。

主要发现

  • 未调整分析:死亡HR 1.35(95%CI 0.70-2.60,P=0.37),死亡或Fontan失败HR 1.39(95%CI 0.83-2.34,P=0.21)。
  • 倾向匹配131对后:死亡HR 1.30(95%CI 0.49-3.41,P=0.60),死亡或Fontan失败HR 0.92(95%CI 0.46-1.85,P=0.82)。

关键数值与推荐

  • 主要终点为死亡或Fontan失败。
  • 肺动脉扩大组中位随访6.4年,死亡10例(6.5%);非扩大组中位随访10.5年,死亡95例(7.4%)。

临床怎么用

  • 对Fontan术前或术中需行肺动脉扩大的患者,可依据此结果判断远期结局风险未显著增加。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Long-term data on the impact of pulmonary artery (PA) augmentation in patients who underwent the Fontan procedure are lacking. The aim of this study was to examine whether surgical or transcatheter PA augmentation at or prior to the Fontan procedure adversely affects the outcomes. METHODS: Data of 1436 patients from the Australia-New Zealand Fontan Registry (1975-2015) were analysed. Primary end point was death or Fontan failure. Cox regression with propensity score matching was used to determine risk or benefit conferred by PA augmentation. RESULTS: Forty-eight (3.3%) patients underwent PA augmentation following cavopulmonary shunt (surgical n = 14, balloon dilatation n = 16 and stent n = 18) and 105 (7.3%) patients underwent PA augmentation at the time of the Fontan procedure (surgical n = 104, stent n = 1). Median follow-up was 6.4 years with 10 deaths (6.5%) in the augmentation group and 10.5 years with 95 deaths (7.4%) in the non-augmentation group. The unadjusted Kaplan-Meier, log-rank test and Cox regression analysis demonstrated no significant difference in both end points between the 2 groups [death: hazard ratio (HR) 1.35, 95% confidence interval (CI) 0.70-2.60; P = 0.37 death or failure: HR 1.39, 95% CI 0.83-2.34; P = 0.21]. The propensity score matching yielded 131 matched pairs, with adequate balance for all covariates (the median residual bias = 0.05). The subsequent Cox regression demonstrated no significant difference in the risks of death (HR 1.30, 95% CI 0.49-3.41; P = 0.60) and death or Fontan failure (HR 0.92, 95% CI 0.46-1.85; P = 0.82). CONCLUSIONS: PA augmentation prior to or at the Fontan procedure does not confer worse long-term outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Shearer L, Justo RN, Marathe SP, et al. Augmentation of the pulmonary arteries at or prior to the Fontan procedure is not associated with worse long-term outcomes: a propensity-matched analysis from the Australia-New Zealand Fontan Registry†. Eur J Cardiothorac Surg. 2019. PMID: 30496386. doi:10.1093/ejcts/ezy376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。